|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 1164 for Erbb2

Category restricted to Publication (x)

0.046s

Categories

Category: Publication
Type Details Score
Publication
First Author: Li H
Year: 2016
Journal: Mamm Genome
Title: Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
Volume: 27
Issue: 11-12
Pages: 556-564
Publication
First Author: Brown N
Year: 2004
Journal: Biol Reprod
Title: Embryo-uterine interactions via the neuregulin family of growth factors during implantation in the mouse.
Volume: 71
Issue: 6
Pages: 2003-11
Publication
First Author: Cardiff RD
Year: 1991
Journal: Am J Pathol
Title: Transgenic oncogene mice. Tumor phenotype predicts genotype.
Volume: 139
Issue: 3
Pages: 495-501
Publication
First Author: Nowakowski TJ
Year: 2011
Journal: PLoS One
Title: Functional dicer is necessary for appropriate specification of radial glia during early development of mouse telencephalon.
Volume: 6
Issue: 8
Pages: e23013
Publication
First Author: Hutchinson JN
Year: 2000
Journal: Oncogene
Title: Transgenic mouse models of human breast cancer.
Volume: 19
Issue: 53
Pages: 6130-7
Publication
First Author: Fabris VT
Year: 2014
Journal: Cancer Genet
Title: From chromosomal abnormalities to the identification of target genes in mouse models of breast cancer.
Volume: 207
Issue: 6
Pages: 233-46
Publication
First Author: Cao Y
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells.
Volume: 104
Issue: 40
Pages: 15852-7
Publication
First Author: Fry EA
Year: 2017
Journal: Int J Cancer
Title: Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
Volume: 140
Issue: 3
Pages: 495-503
Publication
First Author: Kurpios NA
Year: 2003
Journal: J Mammary Gland Biol Neoplasia
Title: Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.
Volume: 8
Issue: 2
Pages: 177-90
Publication
First Author: White MR
Year: 1992
Journal: Oncogene
Title: Cloning and characterization of the mouse neu promoter.
Volume: 7
Issue: 4
Pages: 677-83
Publication
First Author: Perera SA
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
Volume: 106
Issue: 2
Pages: 474-9
Publication
First Author: Gritzapis AD
Year: 2008
Journal: J Immunol
Title: Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties.
Volume: 181
Issue: 1
Pages: 146-54
Publication
First Author: Diodoro MG
Year: 2000
Journal: Int J Cancer
Title: Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression.
Volume: 88
Issue: 3
Pages: 329-35
Publication
First Author: Machiels JP
Year: 2001
Journal: Cancer Res
Title: Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
Volume: 61
Issue: 9
Pages: 3689-97
Publication
First Author: Thomas H
Year: 1996
Journal: Br J Cancer
Title: An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model.
Volume: 73
Issue: 1
Pages: 65-72
Publication
First Author: Guy CT
Year: 1996
Journal: J Biol Chem
Title: Activated neu induces rapid tumor progression.
Volume: 271
Issue: 13
Pages: 7673-8
Publication
First Author: Feldner JC
Year: 2002
Journal: Exp Cell Res
Title: Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization.
Volume: 272
Issue: 2
Pages: 93-108
Publication
First Author: Amici A
Year: 2000
Journal: Gene Ther
Title: DNA vaccination with full-length or truncated neu induces protective immunity against the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Volume: 7
Issue: 8
Pages: 703-6
Publication
First Author: Schechter AL
Year: 1984
Journal: Nature
Title: The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.
Volume: 312
Issue: 5994
Pages: 513-6
Publication
First Author: Semba K
Year: 1985
Journal: Proc Natl Acad Sci U S A
Title: A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
Volume: 82
Issue: 19
Pages: 6497-501
Publication
First Author: Bargmann CI
Year: 1986
Journal: Nature
Title: The neu oncogene encodes an epidermal growth factor receptor-related protein.
Volume: 319
Issue: 6050
Pages: 226-30
Publication
First Author: Nagata Y
Year: 1997
Journal: J Immunol
Title: Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts.
Volume: 159
Issue: 3
Pages: 1336-43
Publication
First Author: Muller WJ
Year: 2003
Journal: Gynecol Oncol
Title: General keynote: expression of epidermal growth factor receptor family in transgenic mouse models of human breast cancer.
Volume: 88
Issue: 1 Pt 2
Pages: S43-6; discussion S52-5
Publication
First Author: Jeruss JS
Year: 2003
Journal: Carcinogenesis
Title: Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model.
Volume: 24
Issue: 4
Pages: 659-64
Publication
First Author: Gallo P
Year: 2005
Journal: Int J Cancer
Title: Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector.
Volume: 113
Issue: 1
Pages: 67-77
Publication
First Author: Stöcklin E
Year: 1993
Journal: J Cell Biol
Title: An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice.
Volume: 122
Issue: 1
Pages: 199-208
Publication
First Author: Provinciali M
Year: 2005
Journal: Int J Cancer
Title: Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Volume: 115
Issue: 1
Pages: 36-45
Publication
First Author: Spadaro M
Year: 2005
Journal: Clin Cancer Res
Title: Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity.
Volume: 11
Issue: 5
Pages: 1941-52
Publication
First Author: Piechocki MP
Year: 2008
Journal: Int J Cancer
Title: Gefitinib prevents cancer progression in mice expressing the activated rat HER2/neu.
Volume: 122
Issue: 8
Pages: 1722-9
Publication
First Author: Rajagopalan V
Year: 2008
Journal: Am J Physiol Heart Circ Physiol
Title: Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction.
Volume: 295
Issue: 2
Pages: H543-54
Publication
First Author: Stukov AN
Year: 2019
Journal: Drug Res (Stuttg)
Title: Enchancement of Toremifene Anti-Tumor Action by Metformin and Unusual Side Effect of Toremifene in Male Transgenic Mice with HER2-Positive Breast Tumor.
Volume: 69
Issue: 12
Pages: 683-687
Publication
First Author: Han BS
Year: 2019
Journal: Sci Rep
Title: Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model.
Volume: 9
Issue: 1
Pages: 2855
Publication
First Author: Guo H
Year: 2012
Journal: J Biol Chem
Title: Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching.
Volume: 287
Issue: 30
Pages: 24941-54
Publication
First Author: Ginzel JD
Year: 2021
Journal: Mol Cancer Res
Title: HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.
Volume: 19
Issue: 10
Pages: 1699-1711
Publication
First Author: Panchenko AV
Year: 2016
Journal: Biogerontology
Title: Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice.
Volume: 17
Issue: 2
Pages: 317-24
Publication
First Author: Yang Y
Year: 2015
Journal: Mol Med Rep
Title: Use of the disulfiram/copper complex for breast cancer chemoprevention in MMTV-erbB2 transgenic mice.
Volume: 12
Issue: 1
Pages: 746-52
Publication
First Author: Xu Z
Year: 2023
Journal: Cardiovasc Res
Title: PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications.
Volume: 119
Issue: 5
Pages: 1250-1264
Publication
First Author: Cordero A
Year: 2023
Journal: J Mammary Gland Biol Neoplasia
Title: Rank ectopic expression in the presence of Neu and MMTV oncogenes alters mammary epithelial cell populations and their tumorigenic potential.
Volume: 28
Issue: 1
Pages: 2
Publication
First Author: Yeh ES
Year: 2011
Journal: J Clin Invest
Title: Hunk is required for HER2/neu-induced mammary tumorigenesis.
Volume: 121
Issue: 3
Pages: 866-79
Publication
First Author: Segatto O
Year: 1993
Journal: Oncogene
Title: Shc products are substrates of erbB-2 kinase.
Volume: 8
Issue: 8
Pages: 2105-12
Publication
First Author: Chen H
Year: 2008
Journal: Cancer Res
Title: Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.
Volume: 68
Issue: 10
Pages: 3637-44
Publication
First Author: Meng L
Year: 2011
Journal: Oncogene
Title: Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis.
Volume: 30
Issue: 25
Pages: 2836-45
Publication  
First Author: Sriram R
Year: 2015
Journal: Breast Cancer Res
Title: Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Volume: 17
Pages: 7
Publication
First Author: Meyer DS
Year: 2014
Journal: Oncogene
Title: Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenance.
Volume: 33
Issue: 3
Pages: 398-402
Publication
First Author: Shen T
Year: 2018
Journal: Oncotarget
Title: Erbin exerts a protective effect against inflammatory bowel disease by suppressing autophagic cell death.
Volume: 9
Issue: 15
Pages: 12035-12049
Publication
First Author: Saeki N
Year: 2000
Journal: Mamm Genome
Title: Gasdermin (Gsdm) localizing to mouse Chromosome 11 is predominantly expressed in upper gastrointestinal tract but significantly suppressed in human gastric cancer cells.
Volume: 11
Issue: 9
Pages: 718-24
Publication
First Author: Hemmi H
Year: 2012
Journal: J Immunol
Title: Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein.
Volume: 188
Issue: 3
Pages: 1147-55
Publication
First Author: Gil-Henn H
Year: 2003
Journal: J Biol Chem
Title: Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells.
Volume: 278
Issue: 18
Pages: 15579-86
Publication
First Author: Dominguez AL
Year: 2008
Journal: Cancer Res
Title: Implications of aging and self-tolerance on the generation of immune and antitumor immune responses.
Volume: 68
Issue: 13
Pages: 5423-31
Publication
First Author: Colnot C
Year: 1998
Journal: Immunology
Title: Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice.
Volume: 94
Issue: 3
Pages: 290-6
Publication
First Author: Brechbuhl HM
Year: 2014
Journal: Am J Physiol Lung Cell Mol Physiol
Title: Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation.
Volume: 307
Issue: 10
Pages: L800-10
Publication
First Author: Liu X
Year: 2015
Journal: Endocrinology
Title: ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice.
Volume: 156
Issue: 1
Pages: 71-9
Publication
First Author: Pinkas-Kramarski R
Year: 1998
Journal: Mol Cell Biol
Title: ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.
Volume: 18
Issue: 10
Pages: 6090-101
Publication
First Author: Tugendreich S
Year: 1993
Journal: Proc Natl Acad Sci U S A
Title: Linking yeast genetics to mammalian genomes: identification and mapping of the human homolog of CDC27 via the expressed sequence tag (EST) data base.
Volume: 90
Issue: 21
Pages: 10031-5
Publication
First Author: Imoto M
Year: 1994
Journal: Exp Cell Res
Title: Enhancement of CDP-DG:inositol transferase activity in src- and erbB2-transformed cells.
Volume: 212
Issue: 1
Pages: 151-4
Publication
First Author: Goji J
Year: 1995
Journal: Am J Pathol
Title: Expression of c-ErbB2 in human neuroblastoma tissues, adrenal medulla adjacent to tumor, and developing mouse neural crest cells.
Volume: 146
Issue: 3
Pages: 660-72
Publication
First Author: Matsuda Y
Year: 1995
Journal: Electrophoresis
Title: Application of fluorescence in situ hybridization in genome analysis of the mouse.
Volume: 16
Issue: 2
Pages: 261-72
Publication
First Author: Jiménez-Farfán D
Year: 2005
Journal: Birth Defects Res A Clin Mol Teratol
Title: EGF-R and erbB-2 in murine tooth development after ethanol exposure.
Volume: 73
Issue: 2
Pages: 65-71
Publication
First Author: Knudsen KA
Year: 2005
Journal: J Cell Biochem
Title: Effect of N-cadherin misexpression by the mammary epithelium in mice.
Volume: 95
Issue: 6
Pages: 1093-107
Publication
First Author: Osipo C
Year: 2007
Journal: Int J Oncol
Title: Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
Volume: 30
Issue: 2
Pages: 509-20
Publication
First Author: Nethery DE
Year: 2005
Journal: J Appl Physiol (1985)
Title: Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice.
Volume: 99
Issue: 1
Pages: 298-307
Publication
First Author: Zhu W
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection.
Volume: 109
Issue: 35
Pages: 14194-9
Publication
First Author: Ho BL
Year: 2021
Journal: FEBS Lett
Title: NRG/ErbB signaling regulates neonatal muscle growth but not neuromuscular contractures in neonatal brachial plexus injury.
Volume: 595
Issue: 5
Pages: 655-666
Publication
First Author: Oh YS
Year: 2011
Journal: PLoS One
Title: Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
Volume: 6
Issue: 8
Pages: e23894
Publication
First Author: Gasca S
Year: 1995
Journal: Dev Genet
Title: Characterization of a gene trap insertion into a novel gene, cordon-bleu, expressed in axial structures of the gastrulating mouse embryo.
Volume: 17
Issue: 2
Pages: 141-54
Publication
First Author: Threadgill DW
Year: 1995
Journal: Science
Title: Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.
Volume: 269
Issue: 5221
Pages: 230-4
Publication
First Author: Roelink H
Year: 1990
Journal: Proc Natl Acad Sci U S A
Title: Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain.
Volume: 87
Issue: 12
Pages: 4519-23
Publication  
First Author: Chen J
Year: 2017
Journal: Cell Discov
Title: A role for ErbB signaling in the induction of reactive astrogliosis.
Volume: 3
Pages: 17044
Publication
First Author: Gallagher EJ
Year: 2017
Journal: Oncogene
Title: Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.
Volume: 36
Issue: 46
Pages: 6462-6471
Publication
First Author: Wang S
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
Volume: 106
Issue: 1
Pages: 151-6
Publication
First Author: Rodriguez OC
Year: 2009
Journal: Am J Pathol
Title: A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.
Volume: 174
Issue: 6
Pages: 2051-60
Publication
First Author: Chan R
Year: 2002
Journal: Mol Cell Biol
Title: The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development.
Volume: 22
Issue: 4
Pages: 1073-8
Publication
First Author: Schmidt N
Year: 2011
Journal: J Cell Biol
Title: Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin.
Volume: 195
Issue: 7
Pages: 1171-84
Publication  
First Author: Nagai Y
Year: 2019
Journal: Front Immunol
Title: PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185erbB2/neu Tumor Immunotherapy.
Volume: 10
Pages: 174
Publication
First Author: Mizutani M
Year: 2012
Journal: J Immunol
Title: The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood.
Volume: 188
Issue: 1
Pages: 29-36
Publication
First Author: Zuo T
Year: 2007
Journal: J Clin Invest
Title: FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Volume: 117
Issue: 12
Pages: 3765-73
Publication
First Author: Fu AK
Year: 2001
Journal: Nat Neurosci
Title: Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction.
Volume: 4
Issue: 4
Pages: 374-81
Publication
First Author: Béguelin W
Year: 2010
Journal: Mol Cell Biol
Title: Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.
Volume: 30
Issue: 23
Pages: 5456-72
Publication
First Author: Stetler-Stevenson WG
Year: 1992
Journal: Genomics
Title: Linkage analysis demonstrates that the Timp-2 locus is on mouse chromosome 11.
Volume: 14
Issue: 3
Pages: 828-9
Publication
First Author: Stein D
Year: 1994
Journal: EMBO J
Title: The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.
Volume: 13
Issue: 6
Pages: 1331-40
Publication
First Author: Carraway KL 3rd
Year: 1996
Journal: Bioessays
Title: Involvement of the neuregulins and their receptors in cardiac and neural development.
Volume: 18
Issue: 4
Pages: 263-6
Publication
First Author: Tzahar E
Year: 1997
Journal: EMBO J
Title: Bivalence of EGF-like ligands drives the ErbB signaling network.
Volume: 16
Issue: 16
Pages: 4938-50
Publication
First Author: Lim H
Year: 1998
Journal: Dev Biol
Title: erbB genes in the mouse uterus: cell-specific signaling by epidermal growth factor (EGF) family of growth factors during implantation.
Volume: 204
Issue: 1
Pages: 97-110
Publication
First Author: Hulit J
Year: 2002
Journal: Biochem Pharmacol
Title: ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1.
Volume: 64
Issue: 5-6
Pages: 827-36
Publication
First Author: Ray D
Year: 2008
Journal: Cancer Res
Title: CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability.
Volume: 68
Issue: 5
Pages: 1251-3
Publication
First Author: Del Monte-Nieto G
Year: 2018
Journal: Nature
Title: Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation.
Volume: 557
Issue: 7705
Pages: 439-445
Publication
First Author: Kwon HS
Year: 2013
Journal: J Biol Chem
Title: Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signaling.
Volume: 288
Issue: 37
Pages: 26357-71
Publication
First Author: Bersell K
Year: 2009
Journal: Cell
Title: Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury.
Volume: 138
Issue: 2
Pages: 257-70
Publication
First Author: Sasaki S
Year: 2005
Journal: Mol Cell Biol
Title: Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality.
Volume: 25
Issue: 17
Pages: 7812-27
Publication
First Author: Lane TF
Year: 1995
Journal: Genes Dev
Title: Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.
Volume: 9
Issue: 21
Pages: 2712-22
Publication
First Author: Bergstein I
Year: 1997
Journal: Genomics
Title: Isolation of two novel WNT genes, WNT14 and WNT15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21.
Volume: 46
Issue: 3
Pages: 450-8
Publication
First Author: Boles MK
Year: 2009
Journal: PLoS Genet
Title: Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxin.
Volume: 5
Issue: 12
Pages: e1000759
Publication
First Author: Hentges KE
Year: 2006
Journal: Gene Expr Patterns
Title: Novel lethal mouse mutants produced in balancer chromosome screens.
Volume: 6
Issue: 6
Pages: 653-65
Publication
First Author: Nanni P
Year: 2012
Journal: PLoS One
Title: Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.
Volume: 7
Issue: 6
Pages: e39626
Publication
First Author: Gore J
Year: 2016
Journal: Cancer Lett
Title: Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Volume: 379
Issue: 1
Pages: 143-53
Publication
First Author: Large MJ
Year: 2014
Journal: PLoS Genet
Title: The epidermal growth factor receptor critically regulates endometrial function during early pregnancy.
Volume: 10
Issue: 6
Pages: e1004451
Publication
First Author: Kramer R
Year: 1996
Journal: Proc Natl Acad Sci U S A
Title: Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development.
Volume: 93
Issue: 10
Pages: 4833-8
Publication
First Author: Breunig JJ
Year: 2015
Journal: Cell Rep
Title: Ets Factors Regulate Neural Stem Cell Depletion and Gliogenesis in Ras Pathway Glioma.
Volume: 12
Issue: 2
Pages: 258-71
Publication
First Author: Huang Z
Year: 2012
Journal: J Biol Chem
Title: Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.
Volume: 287
Issue: 22
Pages: 18091-102
Publication  
First Author: Shneider NA
Year: 2009
Journal: Neural Dev
Title: Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival.
Volume: 4
Pages: 42